Subscribe to our newsletters!
Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Dr Niels Clauson-Kaas, a well-reputed university researcher, founded NCK in 1956. He wanted to create an innovative company with strong competences within research and development in the field of organic chemistry.
His career started at the universities in Copenhagen, Zürich and Haifa. In 1949 he was offered a position as head of an industrial organic synthesis laboratory in Denmark, and in 1956 he decided to start his own company focused on research and development in organic synthesis, providing contract services to the chemical industry.
Dr Niels Clauson-Kaas remained a chemist and a scientist at heart. His reputation as an outstanding chemist was, and still is, a core asset to the company. He headed a group of highly competent and dedicated chemists - and together they created the inspiring and innovative environment, today known as NCK.
In 1983, a foundation was established to buy out Dr Niels Clauson-Kaas. The objective was to build a sustainable company, and continue having an inspiring working environment.
Emphasis was put on life science, and parallel to this, a more ambitious marketing strategy was implemented. From being a regional player, primarily doing business in Europe and Israel, the management successfully expanded the strategy to include the United States and Japan.
NCK provides cutting edge process development and API manufacturing (e.g. process development, analytical development, reference samples, supply of API for toxicology and human studies, API release, ICH stability studies as well as relevant progress reports and GMP documentation) for biotech and pharma companies who want to take NCEs from discovery to commercialization.
NCK offers all relevant services for fulfilling regulatory requirements when applying for an IND / IMPD. NCK is built on the foundation of Synthetic Organic Chemistry, and we have seen and have been involved in most of the latest innovative chemistry.
When doing business with the NCK team, you follow a path of well-integrated processes to minimize risks and ensure success at the end of the journey.
We prefer transparency in every stage of a project. That is why we thoroughly screen a project before accepting the job. That is your guarantee for predictable results.
We are keen about the details, even though the scope of the project may change along the way.
An introduction to our general terms and conditions may be found here.
Dr Niels Clauson-Kaas, a well-reputed university researcher, founded NCK in 1956. He wanted to create an innovative company with strong competences within research and development in the field of organic chemistry.
His career started at the universities in Copenhagen, Zürich and Haifa. In 1949 he was offered a position as head of an industrial organic synthesis laboratory in Denmark, and in 1956 he decided to start his own company focused on research and development in organic synthesis, providing contract services to the chemical industry.
Dr Niels Clauson-Kaas remained a chemist and a scientist at heart. His reputation as an outstanding chemist was, and still is, a core asset to the company. He headed a group of highly competent and dedicated chemists - and together they created the inspiring and innovative environment, today known as NCK.
In 1983, a foundation was established to buy out Dr Niels Clauson-Kaas. The objective was to build a sustainable company, and continue having an inspiring working environment.
Emphasis was put on life science, and parallel to this, a more ambitious marketing strategy was implemented. From being a regional player, primarily doing business in Europe and Israel, the management successfully expanded the strategy to include the United States and Japan.
NCK provides cutting edge process development and API manufacturing (e.g. process development, analytical development, reference samples, supply of API for toxicology and human studies, API release, ICH stability studies as well as relevant progress reports and GMP documentation) for biotech and pharma companies who want to take NCEs from discovery to commercialization.
NCK offers all relevant services for fulfilling regulatory requirements when applying for an IND / IMPD. NCK is built on the foundation of Synthetic Organic Chemistry, and we have seen and have been involved in most of the latest innovative chemistry.
When doing business with the NCK team, you follow a path of well-integrated processes to minimize risks and ensure success at the end of the journey.
We prefer transparency in every stage of a project. That is why we thoroughly screen a project before accepting the job. That is your guarantee for predictable results.
We are keen about the details, even though the scope of the project may change along the way.
An introduction to our general terms and conditions may be found here.
